05:41 PM EDT, 10/28/2024 (MT Newswires) -- Inari Medical ( NARI ) reported a Q3 net loss late Monday of $0.31 per diluted share, compared with net income of $0.05 a year earlier.

Analysts polled by Capital IQ expected a $0.18 loss.

Revenue in the three months ended Sept. 30 rose to $153.4 million from $126.4 million a year earlier.

Analysts surveyed by Capital IQ expected $150.7 million.

In 2024, the medical device company expects revenue of $601.5 million to $604.5 million versus the previous outlook of $594.5 million to $604.5 million.

Analysts project $600 million.

Inari said it continues to expect to reach sustained operating profitability in H1.

The company's shares rose 10% in after-hours activity.

Price: 47.00, Change: +4.44, Percent Change: +10.43